News2019-10-11T16:18:20+01:00

Latest news and thought leadership

The latest from Deallus pharmaceutical and life science industry experts

Deallus sponsoring and speaking at the Pharma CI EU Conference

We are excited to be sponsoring and speaking at the Pharma CI EU conference, held in Rome on 30-31 March 2023. Julie Munch Khan, COO, and Stephen Small, Senior Principal at Deallus will be joining other Competitive Intelligence experts across Pharma, Biotech and Medical Devices.

March 6th, 2023|Categories: News|Tags: , |0 Comments

Overview of current policy for rare disease in China

For the first time after decades of negligence in this area, China published the First List of Rare Diseases (FLRDs). This was a key step in improving and standardising the regulatory system of rare disease management, orphan drug development, and review and approval.

February 27th, 2023|Categories: News, White Paper|Tags: |0 Comments

HIV/AIDS

Human immunodeficiency virus (HIV) is the virus that is responsible for Acquired Immune Deficiency Syndrome (AIDS). HIV continues to be a major global public health issue having claimed the lives of 36.3 million people so far, according to World Health Organization (WHO).

December 1st, 2022|Categories: White Paper, News|Tags: , |0 Comments
Go to Top